{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T14:51:00Z","timestamp":1787237460737,"version":"build-2736575974"},"publisher-location":"Cham","reference-count":74,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783319573113","type":"print"},{"value":"9783319573137","type":"electronic"}],"license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016]]},"DOI":"10.1007\/164_2016_2","type":"book-chapter","created":{"date-parts":[[2016,9,2]],"date-time":"2016-09-02T09:31:23Z","timestamp":1472808683000},"page":"473-488","source":"Crossref","is-referenced-by-count":69,"title":["Toxicity of Antiepileptic Drugs to Mitochondria"],"prefix":"10.1007","author":[{"given":"Josef","family":"Finsterer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,9,3]]},"reference":[{"key":"2_CR1","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1002\/ana.410130620","volume":"13","author":"RJ Allen","year":"1983","unstructured":"Allen RJ, DiMauro S, Coulter DL et al (1983) Kearns-Sayre syndrome with reduced plasma and cerebrospinal fluid folate. Ann Neurol 13:679\u2013682","journal-title":"Ann Neurol"},{"key":"2_CR2","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1111\/j.0013-9580.2004.14104.x","volume":"45","author":"IM Ara\u00fajo","year":"2004","unstructured":"Ara\u00fajo IM, Ambr\u00f3sio AF, Leal EC et al (2004) Neurotoxicity induced by antiepileptic drugs in cultured hippocampal neurons: a comparative study between carbamazepine, oxcarbazepine, and two new putative antiepileptic drugs, BIA 2\u2013024 and BIA 2\u2013093. Epilepsia 45:1498\u20131505","journal-title":"Epilepsia"},{"key":"2_CR3","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/ana.21885","volume":"67","author":"M Asanuma","year":"2010","unstructured":"Asanuma M, Miyazaki I, Diaz-Corrales FJ et al (2010) Neuroprotective effects of zonisamide target astrocyte. Ann Neurol 67:239\u2013249","journal-title":"Ann Neurol"},{"key":"2_CR4","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1017\/S1461145708009802","volume":"12","author":"RF Bachmann","year":"2009","unstructured":"Bachmann RF, Wang Y, Yuan P et al (2009) Common effects of lithium and valproate on mitochondrial functions: protection against methamphetamine-induced mitochondrial damage. Int J Neuropsychopharmacol 12:805\u2013822","journal-title":"Int J Neuropsychopharmacol"},{"key":"2_CR5","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1111\/j.1469-8749.2009.03541.x","volume":"52","author":"C Barnerias","year":"2010","unstructured":"Barnerias C, Saudubray JM, Touati G et al (2010) Pyruvate dehydrogenase complex deficiency: four neurological phenotypes with differing pathogenesis. Dev Med Child Neurol 52:e1\u2013e9","journal-title":"Dev Med Child Neurol"},{"key":"2_CR6","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1177\/0883073809352888","volume":"25","author":"I Berger","year":"2010","unstructured":"Berger I, Segal I, Shmueli D et al (2010) The effect of antiepileptic drugs on mitochondrial activity: a pilot study. J Child Neurol 25:541\u2013545","journal-title":"J Child Neurol"},{"key":"2_CR7","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1002\/ana.410320610","volume":"32","author":"AR Bicknese","year":"1992","unstructured":"Bicknese AR, May W, Hickey WF et al (1992) Early childhood hepatocerebral degeneration misdiagnosed as valproate hepatotoxicity. Ann Neurol 32:767\u2013775","journal-title":"Ann Neurol"},{"key":"2_CR8","first-page":"519","volume":"55","author":"GN Bogdanov","year":"2009","unstructured":"Bogdanov GN, Mishchenko DV, Kotel\u2019nikova RA, Frog ES, Fa\u012dngol\u2019d II, Tat\u2019ianenko LV, Dorokhotova OV, Nartsissov IR (2009) Anticonvulsants as bioantioxidants under stress conditions. Biomed Khim 55:519\u2013524","journal-title":"Biomed Khim"},{"key":"2_CR9","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/j.1528-1167.2009.02259.x","volume":"51","author":"A Cansu","year":"2010","unstructured":"Cansu A, Erdogan D, Serdaroglu A, Take G, Coskun ZK, Gurgen SG (2010) Histologic and morphologic effects of valproic acid and oxcarbazepine on rat uterine and ovarian cells. Epilepsia 51:98\u2013107","journal-title":"Epilepsia"},{"key":"2_CR10","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0304-3940(00)01206-4","volume":"288","author":"V Cardile","year":"2000","unstructured":"Cardile V, Pavone A, Renis M, Russo A, Perciavalle V (2000) Biological effects of tiagabine on primary cortical astrocyte cultures of rat. Neurosci Lett 288:49\u201352","journal-title":"Neurosci Lett"},{"key":"2_CR11","doi-asserted-by":"crossref","first-page":"912","DOI":"10.33588\/rn.2910.99062","volume":"29","author":"M Castro-Cago","year":"1999","unstructured":"Castro-Cago M, Gonz\u00e1lez-Conde V, Fern\u00e1ndez-Seara MJ et al (1999) Early mitochondrial encephalomyopathy due to complex IV deficiency consistent with Alpers-Huttenlocher syndrome: report of two cases. Rev Neurol 29:912\u2013917","journal-title":"Rev Neurol"},{"key":"2_CR12","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1515\/DMDI.2005.21.2.109","volume":"21","author":"M Cengiz","year":"2005","unstructured":"Cengiz M, Y\u00fcksel A, Ozaydin A, Ozkili\u00e7 A, Cetinel O, Seven M (2005) The effects of vigabatrin on rat liver antioxidant status. Drug Metabol Drug Interact 21:109\u2013115","journal-title":"Drug Metabol Drug Interact"},{"key":"2_CR13","first-page":"133","volume":"153","author":"B Chabrol","year":"1994","unstructured":"Chabrol B, Mancini J, Chretien D et al (1994) Valproate-induced hepatic failure in a case of cytochrome c oxidase deficiency. Eur J Pediatr 153:133\u2013135","journal-title":"Eur J Pediatr"},{"key":"2_CR14","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1158\/1541-7786.MCR-10-0471","volume":"9","author":"X Chen","year":"2011","unstructured":"Chen X, Wong JY, Wong P, Radany EH (2011) Low-dose valproic acid enhances radiosensitivity of prostate cancer through acetylated p53-dependent modulation of mitochondrial membrane potential and apoptosis. Mol Cancer Res 9:448\u2013461","journal-title":"Mol Cancer Res"},{"key":"2_CR15","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.braindev.2007.12.006","volume":"30","author":"T Chiyonobu","year":"2008","unstructured":"Chiyonobu T, Noda R, Yoshida M et al (2008) Intestinal pseudo-obstruction in a patient with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) associated with phenytoin therapy. Brain Dev 30:430\u2013433","journal-title":"Brain Dev"},{"key":"2_CR16","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1007\/s11064-013-1181-2","volume":"38","author":"S Condello","year":"2013","unstructured":"Condello S, Curr\u00f2 M, Ferlazzo N, Costa G, Visalli G, Caccamo D, Pisani LR, Costa C, Calabresi P, Ientile R, Pisani F (2013) Protective effects of zonisamide against rotenone-induced neurotoxicity. Neurochem Res 38:2631\u20132639","journal-title":"Neurochem Res"},{"key":"2_CR17","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1046\/j.1471-4159.1997.68031191.x","volume":"68","author":"BP Connop","year":"1997","unstructured":"Connop BP, Boegman RJ, Beninger RJ et al (1997) Malonate-induced degeneration of basal forebrain cholinergic neurons: attenuation by lamotrigine, MK-801, and 7-nitroindazole. J Neurochem 68:1191\u20131199","journal-title":"J Neurochem"},{"key":"2_CR18","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.expneurol.2009.11.002","volume":"221","author":"C Costa","year":"2010","unstructured":"Costa C, Tozzi A, Luchetti E et al (2010) Electrophysiological actions of zonisamide on striatal neurons: Selective neuroprotection against complex I mitochondrial dysfunction. Exp Neurol 221:217\u2013224","journal-title":"Exp Neurol"},{"key":"2_CR19","doi-asserted-by":"crossref","first-page":"8040","DOI":"10.1523\/JNEUROSCI.1947-08.2008","volume":"28","author":"C Costa","year":"2008","unstructured":"Costa C, Belcastro V, Tozzi A et al (2008) Electrophysiology and pharmacology of striatal neuronal dysfunction induced by mitochondrial complex I inhibition. J Neurosci 28:8040\u20138052","journal-title":"J Neurosci"},{"key":"2_CR20","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1177\/0883073814538511","volume":"29","author":"ST Demarest","year":"2014","unstructured":"Demarest ST, Whitehead MT, Turnacioglu S, Pearl PL, Gropman AL (2014) Phenotypic analysis of epilepsy in the mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes-associated mitochondrial DNA A3243G mutation. J Child Neurol 29:1249\u20131256","journal-title":"J Child Neurol"},{"key":"2_CR21","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1055\/s-2003-43258","volume":"34","author":"I Desguerre","year":"2003","unstructured":"Desguerre I, Pinton F, Nabbout R, Moutard ML, N\u2019Guyen S, Marsac C, Ponsot G, Dulac O (2003) Infantile spasms with basal ganglia MRI hypersignal may reveal mitochondrial disorder due to T8993G MT DNA mutation. Neuropediatrics 34:265\u2013269","journal-title":"Neuropediatrics"},{"key":"2_CR22","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1016\/j.bmcl.2005.03.032","volume":"15","author":"G Simone De","year":"2005","unstructured":"De Simone G, Di Fiore A, Menchise V et al (2005) Carbonic anhydrase inhibitors. Zonisamide is an effective inhibitor of the cytosolic isozyme II and mitochondrial isozyme V: solution and X-ray crystallographic studies. Bioorg Med Chem Lett 15:2315\u20132320","journal-title":"Bioorg Med Chem Lett"},{"key":"2_CR23","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.pnpbp.2007.12.017","volume":"32","author":"A Dhir","year":"2008","unstructured":"Dhir A, Akula KK, Kulkarni SK (2008) Tiagabine, a GABA uptake inhibitor, attenuates 3-nitropropionic acid-induced alterations in various behavioral and biochemical parameters in rats. Prog Neuropsychopharmacol Biol Psychiatry 32:835\u2013843","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"suppl 1","key":"2_CR24","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1111\/j.1528-1157.2000.tb06047.x","volume":"41","author":"SJ Dodgson","year":"2000","unstructured":"Dodgson SJ, Shank RP, Maryanoff BE (2000) Topiramate as an inhibitor of carbonic anhydrase isoenzymes. Epilepsia 41(suppl 1):S35\u2013S39","journal-title":"Epilepsia"},{"key":"2_CR25","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/jbt.21542","volume":"28","author":"MA Eghbal","year":"2014","unstructured":"Eghbal MA, Taziki S, Sattari MR (2014) Mechanisms of phenytoin-induced toxicity in freshly isolated rat hepatocytes and the protective effects of taurine and\/or melatonin. J Biochem Mol Toxicol 28:111\u2013118","journal-title":"J Biochem Mol Toxicol"},{"key":"2_CR26","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1517\/17425255.2012.644535","volume":"8","author":"J Finsterer","year":"2012","unstructured":"Finsterer J, Zarrouk-Mahjoub S (2012) Mitochondrial toxicity of antiepileptic drugs and their tolerability in mitochondrial disorders. Expert Opin Drug Metab Toxicol 8:71\u201379","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"2_CR27","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.eplepsyres.2006.09.005","volume":"73","author":"JE Gibbs","year":"2007","unstructured":"Gibbs JE, Cock HR (2007) Administration of levetiracetam after prolonged status epilepticus does not protect from mitochondrial dysfunction in a rodent model. Epilepsy Res 73:208\u2013212","journal-title":"Epilepsy Res"},{"key":"2_CR28","first-page":"452P","volume":"50","author":"JC Gilbert","year":"1974","unstructured":"Gilbert JC, Scott AK, Wyllie MG (1974) Proceedings: effects of ethosuximide on adenosine triphosphatase activities of some subcellular fractions prepared from rat cerebral cortex. Br J Pharmacol 50:452P\u2013453P","journal-title":"Br J Pharmacol"},{"key":"2_CR29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0920-1211(95)00028-9","volume":"22","author":"A Goldlust","year":"1995","unstructured":"Goldlust A, Su TZ, Welty DF, Taylor CP, Oxender DL (1995) Effects of anticonvulsant drug gabapentin on the enzymes in metabolic pathways of glutamate and GABA. Epilepsy Res 22:1\u201311","journal-title":"Epilepsy Res"},{"key":"2_CR30","doi-asserted-by":"crossref","first-page":"37246","DOI":"10.1074\/jbc.M506486200","volume":"280","author":"M Goto","year":"2005","unstructured":"Goto M, Miyahara I, Hirotsu K et al (2005) Structural determinants for branched-chain aminotransferase isozyme-specific inhibition by the anticonvulsant drug gabapentin. J Biol Chem 280:37246\u201337256","journal-title":"J Biol Chem"},{"key":"2_CR31","doi-asserted-by":"crossref","first-page":"547","DOI":"10.4103\/0253-7613.121266","volume":"45","author":"ND Grover","year":"2013","unstructured":"Grover ND, Limaye RP, Gokhale DV, Patil TR (2013) Zonisamide: a review of the clinical and experimental evidence for its use in Parkinson\u2019s disease. Indian J Pharmacol 45:547\u2013555","journal-title":"Indian J Pharmacol"},{"key":"2_CR32","first-page":"1552","volume":"126","author":"AH Hakonen","year":"2010","unstructured":"Hakonen AH, Isohanni P, Rantam\u00e4ki M et al (2010) Mitochondrial recessive ataxia syndrome (MIRAS) and valproate toxicity. Duodecim 126:1552\u20131559","journal-title":"Duodecim"},{"key":"2_CR33","first-page":"336","volume":"31","author":"J Hroudova","year":"2010","unstructured":"Hroudova J, Fisar Z (2010) Activities of respiratory chain complexes and citrate synthase influenced by pharmacologically different antidepressants and mood stabilizers. Neuro Endocrinol Lett 31:336\u2013342","journal-title":"Neuro Endocrinol Lett"},{"key":"2_CR34","doi-asserted-by":"crossref","unstructured":"Hsu YC, Yang FC, Perng CL et al (2012) Adult-onset of mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) syndrome presenting as acute meningoencephalitis: a case report. J Emerg Med 43(3):e163\u2013e166","DOI":"10.1016\/j.jemermed.2009.10.021"},{"key":"2_CR35","doi-asserted-by":"crossref","first-page":"846S","DOI":"10.1093\/jn\/131.3.846S","volume":"131","author":"SM Hutson","year":"2001","unstructured":"Hutson SM, Lieth E, LaNoue KF (2001) Function of leucine in excitatory neurotransmitter metabolism in the central nervous system. J Nutr 131:846S\u2013850S","journal-title":"J Nutr"},{"key":"2_CR36","first-page":"870","volume":"32","author":"K Iwanga","year":"1992","unstructured":"Iwanga K, Mori K, Inoue M, Yoshimura T, Tanno Y (1992) Myoclonus epilepsy associated with ragged-red fibers--report of a patient with negative myoclonus. Rinsho Shinkeigaku 32:870\u2013873","journal-title":"Rinsho Shinkeigaku"},{"key":"2_CR37","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1034\/j.1399-3046.2000.00115.x","volume":"4","author":"N Kayihan","year":"2000","unstructured":"Kayihan N, Nennesmo I, Ericzon BG et al (2000) Fatal deterioration of neurological disease after orthotopic liver transplantation for valproic acid-induced liver damage. Pediatr Transplant 4:211\u2013214","journal-title":"Pediatr Transplant"},{"key":"2_CR38","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.tox.2015.03.001","volume":"331","author":"T Komulainen","year":"2015","unstructured":"Komulainen T, Lodge T, Hinttala R, Bolszak M, Pietil\u00e4 M, Koivunen P, Hakkola J, Poulton J, Morten KJ, Uusimaa J (2015) Sodium valproate induces mitochondrial respiration dysfunction in HepG2 in vitro cell model. Toxicology 331:47\u201356","journal-title":"Toxicology"},{"key":"2_CR39","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1034\/j.1600-0676.2000.020004346.x","volume":"20","author":"S Kr\u00e4henb\u00fchl","year":"2000","unstructured":"Kr\u00e4henb\u00fchl S, Brandner S, Kleinle S et al (2000) Mitochondrial diseases represent a risk factor for valproate-induced fulminant liver failure. Liver 20:346\u2013348","journal-title":"Liver"},{"key":"2_CR40","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1111\/j.0013-9580.2004.13504.x","volume":"45","author":"AP Kudin","year":"2004","unstructured":"Kudin AP, Debska-Vielhaber G, Vielhaber S et al (2004) The mechanism of neuroprotection by topiramate in an animal model of epilepsy. Epilepsia 45:1478\u20131487","journal-title":"Epilepsia"},{"key":"2_CR41","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.ejphar.2011.11.030","volume":"674","author":"P Kumar","year":"2012","unstructured":"Kumar P, Kalonia H, Kumar A (2012) Possible GABAergic mechanism in the neuroprotective effect of gabapentin and lamotrigine against 3-nitropropionic acid induced neurotoxicity. Eur J Pharmacol 674:265\u2013274","journal-title":"Eur J Pharmacol"},{"key":"2_CR42","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1203\/PDR.0b013e31806790d7","volume":"62","author":"E Lagrue","year":"2007","unstructured":"Lagrue E, Chalon S, Bodard S et al (2007) Lamotrigine is neuroprotective in the energy deficiency model of MPTP intoxicated mice. Pediatr Res 62:14\u201319","journal-title":"Pediatr Res"},{"key":"2_CR43","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ejphar.2006.03.076","volume":"539","author":"JS Lai","year":"2006","unstructured":"Lai JS, Zhao C, Warsh JJ et al (2006) Cytoprotection by lithium and valproate varies between cell types and cellular stresses. Eur J Pharmacol 539:18\u201326","journal-title":"Eur J Pharmacol"},{"key":"2_CR44","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1007\/s004310050663","volume":"156","author":"CW Lam","year":"1997","unstructured":"Lam CW, Lau CH, Williams JC et al (1997) Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS) triggered by valproate therapy. Eur J Pediatr 156:562\u2013564","journal-title":"Eur J Pediatr"},{"key":"2_CR45","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1002\/hep.27712","volume":"61","author":"S Li","year":"2015","unstructured":"Li S, Guo J, Ying Z, Chen S, Yang L, Chen K, Long Q, Qin D, Pei D, Liu X (2015) Valproic acid-induced hepatotoxicity in Alpers syndrome is associated with mitochondrial permeability transition pore opening-dependent apoptotic sensitivity in an induced pluripotent stem cell model. Hepatology 61:1730\u20131739","journal-title":"Hepatology"},{"key":"2_CR46","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s11011-006-9039-9","volume":"22","author":"CM Lin","year":"2007","unstructured":"Lin CM, Thajeb P (2007) Valproic acid aggravates epilepsy due to MELAS in a patient with an A3243G mutation of mitochondrial DNA. Metab Brain Dis 22:105\u2013109","journal-title":"Metab Brain Dis"},{"key":"2_CR47","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jns.2005.11.021","volume":"243","author":"M Mancuso","year":"2006","unstructured":"Mancuso M, Galli R, Pizzanelli C et al (2006) Antimyoclonic effect of levetiracetam in MERRF syndrome. J Neurol Sci 243:97\u201399","journal-title":"J Neurol Sci"},{"key":"2_CR48","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1159\/000322544","volume":"18","author":"D Marmolino","year":"2010","unstructured":"Marmolino D, Manto M (2010) Pregabalin antagonizes copper-induced toxicity in the brain: in vitro and in vivo studies. Neurosignals 18:210\u2013222","journal-title":"Neurosignals"},{"key":"2_CR49","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1684\/epd.2012.0543","volume":"14","author":"MH Martikainen","year":"2012","unstructured":"Martikainen MH, P\u00e4iv\u00e4rinta M, J\u00e4\u00e4skel\u00e4inen S, Majamaa K (2012) Successful treatment of POLG-related mitochondrial epilepsy with antiepileptic drugs and low glycaemic index diet. Epileptic Disord 14:438\u2013441","journal-title":"Epileptic Disord"},{"key":"2_CR50","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1007\/s12640-009-9090-5","volume":"17","author":"B Monti","year":"2010","unstructured":"Monti B, Gatta V, Piretti F, Raffaelli SS, Virgili M, Contestabile A (2010) Valproic acid is neuroprotective in the rotenone rat model of Parkinson\u2019s disease: involvement of alpha-synuclein. Neurotox Res 17:130\u2013141","journal-title":"Neurotox Res"},{"key":"2_CR51","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1016\/j.clinbiochem.2013.07.003","volume":"46","author":"MG Neuman","year":"2013","unstructured":"Neuman MG, Nanau RM, Shekh-Ahmad T, Yagen B, Bialer M (2013) Valproic acid derivatives signal for apoptosis and repair in vitro. Clin Biochem 46:1532\u20131537","journal-title":"Clin Biochem"},{"key":"2_CR52","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/0006-2952(92)90590-F","volume":"43","author":"S Ponchaut","year":"1992","unstructured":"Ponchaut S, van Hoof F, Veitch K (1992) Cytochrome aa3 depletion is the cause of the deficient mitochondrial respiration induced by chronic valproate administration. Biochem Pharmacol 43:644\u2013647","journal-title":"Biochem Pharmacol"},{"key":"2_CR53","doi-asserted-by":"crossref","first-page":"CR203","DOI":"10.12659\/MSM.881716","volume":"17","author":"E Pronicka","year":"2011","unstructured":"Pronicka E, Weglewska-Jurkiewicz A, Pronicki M et al (2011) Drug-resistant epilepsia and fulminant valproate liver toxicity. Alpers-Huttenlocher syndrome in two children confirmed post mortem by identification of p.W748S mutation in POLG gene. Med Sci Monit 17:CR203\u2013CR209","journal-title":"Med Sci Monit"},{"key":"2_CR54","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1177\/088307380001500709","volume":"15","author":"M Rasmussen","year":"2000","unstructured":"Rasmussen M, Sanengen T, Skullerud K et al (2000) Evidence that Alpers-Huttenlocher syndrome could be a mitochondrial disease. J Child Neurol 15:473\u2013477","journal-title":"J Child Neurol"},{"key":"2_CR55","unstructured":"Ray S (ed) (2014) Side effects of drugs annual. Hardbound, 836, Published: December 2014. ISBN 13: 978-0-444-63407-8"},{"key":"2_CR56","doi-asserted-by":"crossref","first-page":"470","DOI":"10.2165\/00003088-199631060-00005","volume":"31","author":"R Riva","year":"1996","unstructured":"Riva R, Albani F, Contin M et al (1996) Pharmacokinetic interactions between antiepileptic drugs. Clinical considerations. Clin Pharmacokinet 31:470\u2013493","journal-title":"Clin Pharmacokinet"},{"key":"2_CR57","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3389\/fneur.2014.00017","volume":"5","author":"SK Rogers","year":"2014","unstructured":"Rogers SK, Shapiro LA, Tobin RP, Tow B, Zuzek A, Mukherjee S, Newell-Rogers MK (2014) Levetiracetam differentially alters CD95 expression of neuronal cells and the mitochondrial membrane potential of immune and neuronal cells in vitro. Front Neurol 5:17","journal-title":"Front Neurol"},{"key":"2_CR58","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/S0026-895X(25)10366-0","volume":"30","author":"L Rumbach","year":"1986","unstructured":"Rumbach L, Mutet C, Cremel G et al (1986) Effects of sodium valproate on mitochondrial membranes: electron paramagnetic resonance and transmembrane protein movement studies. Mol Pharmacol 30:270\u2013273","journal-title":"Mol Pharmacol"},{"key":"2_CR59","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.seizure.2010.01.002","volume":"19","author":"RP Saneto","year":"2010","unstructured":"Saneto RP, Lee IC, Koenig MK et al (2010) POLG DNA testing as an emerging standard of care before instituting valproic acid therapy for pediatric seizure disorders. Seizure 19:140\u2013146","journal-title":"Seizure"},{"key":"2_CR60","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.tiv.2008.03.004","volume":"22","author":"NA Santos","year":"2008","unstructured":"Santos NA, Medina WS, Martins NM et al (2008a) Aromatic antiepileptic drugs and mitochondrial toxicity: effects on mitochondria isolated from rat liver. Toxicol In Vitro 22:1143\u20131152","journal-title":"Toxicol In Vitro"},{"key":"2_CR61","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1016\/j.tiv.2008.08.004","volume":"22","author":"NA Santos","year":"2008","unstructured":"Santos NA, Medina WS, Martins NM et al (2008b) Involvement of oxidative stress in the hepatotoxicity induced by aromatic antiepileptic drugs. Toxicol In Vitro 22:1820\u20131824","journal-title":"Toxicol In Vitro"},{"key":"2_CR62","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1471-2377-11-4","volume":"11","author":"A Schaller","year":"2011","unstructured":"Schaller A, Hahn D, Jackson CB et al (2011) Molecular and biochemical characterisation of a novel mutation in POLG associated with Alpers syndrome. BMC Neurol 11:4","journal-title":"BMC Neurol"},{"key":"2_CR63","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1007\/s11011-014-9645-x","volume":"30","author":"M Schinwelski","year":"2015","unstructured":"Schinwelski M, Kierdaszuk B, Dulski J, To\u0144ska K, Kodro\u0144 A, Sitek EJ, Bartnik E, Kami\u0144ska A, Kwieci\u0144ski H, S\u0142awek J (2015) Changing phenotypic expression in a patient with a mitochondrial encephalopathy due to 13042G\u2009>\u2009A de novo mutation--a 5 year follow up. Metab Brain Dis 30:1083\u20131085","journal-title":"Metab Brain Dis"},{"key":"2_CR64","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0887-8994(97)00030-1","volume":"16","author":"MJ Schwabe","year":"1997","unstructured":"Schwabe MJ, Dobyns WB, Burke B et al (1997) Valproate-induced liver failure in one of two siblings with Alpers disease. Pediatr Neurol 16:337\u2013343","journal-title":"Pediatr Neurol"},{"key":"2_CR65","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1002\/mus.21157","volume":"39","author":"O Shchelochkov","year":"2009","unstructured":"Shchelochkov O, Wong LJ, Shaibani A et al (2009) Atypical presentation of VLCAD deficiency associated with a novel ACADVL splicing mutation. Muscle Nerve 39:374\u2013382","journal-title":"Muscle Nerve"},{"key":"2_CR66","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s00401-003-0698-x","volume":"106","author":"A Simonati","year":"2003","unstructured":"Simonati A, Filosto M, Savio C et al (2003) Features of cell death in brain and liver, the target tissues of progressive neuronal degeneration of childhood with liver disease (Alpers-Huttenlocher disease). Acta Neuropathol 106:57\u201365","journal-title":"Acta Neuropathol"},{"key":"2_CR67","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ymgme.2014.03.006","volume":"112","author":"KS Sitarz","year":"2014","unstructured":"Sitarz KS, Elliott HR, Karaman BS, Relton C, Chinnery PF, Horvath R (2014) Valproic acid triggers increased mitochondrial biogenesis in POLG-deficient fibroblasts. Mol Genet Metab 112:57\u201363","journal-title":"Mol Genet Metab"},{"key":"2_CR68","doi-asserted-by":"crossref","first-page":"e103","DOI":"10.1016\/j.ijcard.2009.05.066","volume":"149","author":"C St\u00f6llberger","year":"2011","unstructured":"St\u00f6llberger C, H\u00f6ftberger R, Finsterer J (2011) Lamotrigine-trigged obstructive hypertrophic cardiomyopathy, epilepsy and metabolic myopathy. Int J Cardiol 149:e103\u2013e105","journal-title":"Int J Cardiol"},{"key":"2_CR69","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2009.02.040","volume":"1266","author":"Y Ueda","year":"2009","unstructured":"Ueda Y, Doi T, Takaki M, Nagatomo K, Nakajima A, Willmore LJ (2009) Levetiracetam enhances endogenous antioxidant in the hippocampus of rats: in vivo evaluation by brain microdialysis combined with ESR spectroscopy. Brain Res 1266:1\u20137","journal-title":"Brain Res"},{"key":"2_CR70","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0014-2999(98)00648-7","volume":"359","author":"EM Urbanska","year":"1998","unstructured":"Urbanska EM, Blaszczak P, Saran T, Kleinrok Z, Turski WA (1998) Mitochondrial toxin 3-nitropropionic acid evokes seizures in mice. Eur J Pharmacol 359:55\u201358","journal-title":"Eur J Pharmacol"},{"key":"2_CR71","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1111\/j.1528-1167.2008.01544.x","volume":"49","author":"J Uusimaa","year":"2008","unstructured":"Uusimaa J, Hinttala R, Rantala H et al (2008) Homozygous W748S mutation in the POLG1 gene in patients with juvenile-onset Alpers syndrome and status epilepticus. Epilepsia 49:1038\u20131045","journal-title":"Epilepsia"},{"key":"2_CR72","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1002\/acn3.200","volume":"2","author":"KR Vogel","year":"2015","unstructured":"Vogel KR, Ainslie GR, Jansen EE, Salomons GS, Gibson KM (2015) Torin 1 partially corrects vigabatrin-induced mitochondrial increase in mouse. Ann Clin Transl Neurol 2:699\u2013706","journal-title":"Ann Clin Transl Neurol"},{"key":"2_CR73","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1111\/j.1528-1167.2008.01877.x","volume":"50","author":"NI Wolf","year":"2009","unstructured":"Wolf NI, Rahman S, Schmitt B et al (2009) Status epilepticus in children with Alpers\u2019 disease caused by POLG1 mutations: EEG and MRI features. Epilepsia 50:1596\u20131607","journal-title":"Epilepsia"},{"key":"2_CR74","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00210-004-0959-9","volume":"370","author":"B Zucker","year":"2004","unstructured":"Zucker B, Ludin DE, Gerds TA, L\u00fccking CH, Landwehrmeyer GB, Feuerstein TJ (2004) Gabapentin-lactam, but not gabapentin, reduces protein aggregates and improves motor performance in a transgenic mouse model of Huntington\u2019s disease. Naunyn Schmiedebergs Arch Pharmacol 370:131\u2013139","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"}],"container-title":["Handbook of Experimental Pharmacology","Pharmacology of Mitochondria"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/164_2016_2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T12:17:09Z","timestamp":1749557829000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/164_2016_2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"ISBN":["9783319573113","9783319573137"],"references-count":74,"URL":"https:\/\/doi.org\/10.1007\/164_2016_2","relation":{},"ISSN":["0171-2004","1865-0325"],"issn-type":[{"value":"0171-2004","type":"print"},{"value":"1865-0325","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}